Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
23,06 USD | +1,47% | +8,14% | -15,06% |
Vakgebied
Aantal werknemers: 436
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Genetic Medicines
100,0
%
| 61 | 100,0 % | 378 | 100,0 % | +520,01% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 61 | 100,0 % | 378 | 100,0 % | +520,01% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Evans
CEO | Chief Executive Officer | 46 | 01-01-17 |
President | 55 | 01-02-18 | |
Director of Finance/CFO | 47 | 01-08-19 | |
Gopi Shanker
CTO | Chief Tech/Sci/R&D Officer | - | 21-03-23 |
Amy Simon
CTO | Chief Tech/Sci/R&D Officer | - | 15-03-21 |
Manmohan Singh
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-07-18 |
Brian Riley
PRN | Corporate Officer/Principal | 47 | 01-09-19 |
Susan O'Connor
HRO | Human Resources Officer | 61 | 01-08-17 |
Christine Bellon
LAW | General Counsel | - | 01-04-19 |
Suzanne Fleming
AUD | Comptroller/Controller/Auditor | 63 | 01-02-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Graham Cooper
BRD | Director/Board Member | 54 | 10-10-19 |
John Maraganore
BRD | Director/Board Member | 60 | 05-11-21 |
Mark Fishman
BRD | Director/Board Member | 72 | 01-05-18 |
Kristina Burow
BRD | Director/Board Member | 50 | 01-06-17 |
Director/Board Member | 68 | 10-01-21 | |
John Evans
CEO | Chief Executive Officer | 46 | 01-01-17 |
Christi L. Shaw
BRD | Director/Board Member | 57 | 14/12 |
Carole Ho
BRD | Director/Board Member | 51 | 15-11-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 82 310 167 | 80 795 167 ( 98,16 %) | 0 | 98,16 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
PRIME MEDICINE, INC. 1.34% | 1 608 337 | 1.34% | 11 258 359 $ |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-15,06% | 1,8 mld. | |
+24,58% | 48,09 mld. | |
+46,90% | 40,62 mld. | |
-3,21% | 40,43 mld. | |
-6,20% | 28,36 mld. | |
+9,31% | 24,89 mld. | |
-20,58% | 19,01 mld. | |
+28,55% | 12,09 mld. | |
+0,51% | 11,88 mld. | |
-1,19% | 11,8 mld. |
- Beurs
- Aandelen
- Koers BEAM
- Onderneming Beam Therapeutics Inc.